Stepan (SCL) Q2 2026: Surfactant EBITDA Up 59% as Catalyst Savings and Volume Spur Margin Recovery
Stepan’s Q2 marked a sharp inflection in profitability as surfactant and polymer segments delivered broad-based volume and margin gains, powered by disciplined pricing and Project Catalyst cost-out. Management flagged pre-buying and raw material volatility as transient tailwinds, signaling a more normalized second half. Investors should watch for sustained margin discipline and further asset optimization as the company targets $100 million in Catalyst savings.
Summary
- Surfactant Margin Rebound: Pricing power and Catalyst savings drove a step-change in segment profitability.
- Asset Optimization Momentum: Pasadena ramp-up and site closures support network efficiency and future cost leverage.
- Second-Half Normalization: Volume pull-forward and raw material volatility temper expectations for Q3 and Q4.
Business Overview
Stepan Company manufactures specialty and intermediate chemicals, operating through three primary segments: surfactants, polymers, and specialty products. Surfactants, surface-active agents used in detergents and cleaning solutions, comprise the largest business, followed by polymers, polyols and anhydrides used in insulation and coatings, and a smaller specialty products division. Revenue is generated through direct sales to industrial, consumer, and agricultural end markets, with North America as the largest geography.
Performance Analysis
Q2 saw a pronounced improvement in earnings quality as adjusted EBITDA rose 45% year over year, driven by a combination of organic volume growth, margin recovery, and the ongoing realization of Project Catalyst cost savings. Surfactants led the charge, with net sales up 18% and adjusted EBITDA climbing 59%, as disciplined pricing actions and pass-through mechanisms offset raw material inflation. Polymers delivered a 22% EBITDA increase, propelled by double-digit North American volume gains—especially in rigid polyols and the high-growth spray foam line—though Europe and Asia remained relatively soft.
Specialty products saw modest top-line growth but slight EBITDA contraction due to less favorable mix. Working capital requirements rose on higher sales and raw material costs, resulting in negative free cash flow this quarter, though leverage improved to 2.5x. Management highlighted that $5-$10 million of Q2 EBITDA was tied to pre-buying, suggesting some pull-forward of demand. Adjusted corporate expenses rose 17% on higher incentive compensation and inflation.
- Segment Outperformance: Surfactants and polymers contributed the majority of incremental earnings, with surfactants accounting for the largest share of revenue and profit gains.
- Cost Discipline: Project Catalyst delivered $18–$20 million of quarterly savings, tracking toward a $22 million run-rate by year-end.
- Volume Dynamics: Organic volume grew 6% overall, with surfactants up 7% and polymers up 5%, though management noted a portion was pre-buying related to geopolitical and supply chain uncertainty.
Overall, Stepan’s Q2 reflected both underlying share gains in core markets and temporary tailwinds from customer inventory behavior, setting up a more measured outlook for the second half.
Executive Commentary
"Growth-based volume growth and margin recovery, together with initial benefits from project catalyst actions, drove significant improvement in earnings. I want to highlight a few elements of our second quarter performance. Adjusted EBITDA was $74 million, up 45% versus the prior year, with all three levers contributing to the results."
Luis Rojo, President and Chief Executive Officer
"Adjusted net income was $27.1 million, or $1.18 per diluted share, up 126%, versus $12 million, or $0.52 per diluted share, in the prior year. The increase in adjusted net income was primarily due to increased earnings in surfactants and in polymers, partially offset by higher corporate expenses and a higher tax provision."
Ruben Velasquez, Vice President and Chief Financial Officer
Strategic Positioning
1. Project Catalyst: Cost-Out and Asset Optimization
Project Catalyst, Stepan’s multi-year efficiency initiative, is central to the company’s margin expansion and capital discipline. The program targets $100 million in pre-tax savings over two years, with 60% expected to be realized in 2026. Actions include site closures (Fieldsboro, New Jersey), asset decommissioning, and a 100-position salaried workforce reduction, all designed to streamline operations and consolidate volume into more efficient plants. Pasadena, Texas, is now running at 75–80% utilization and is ahead of savings targets, supporting the company’s specialty product ambitions.
2. Commercial Discipline: Pricing and Pass-Through Execution
Margin recovery was enabled by disciplined pricing and contractual pass-through mechanisms, allowing Stepan to offset raw material inflation. Management emphasized that this approach remained unchanged from prior cycles, with variability in raw material costs (such as coconut oil and petrochemicals) managed through a blend of contract structures and inventory timing. While not at normalized margin levels, the company is committed to gradual improvement and customer value delivery as price and cost dynamics stabilize.
3. Market Diversification and Share Gains
Stepan’s growth was broad-based, with strategic emphasis on Tier 2 and Tier 3 customers, oilfield, agriculture, and construction end markets. In North America surfactants, the company added 500 new customer-product combinations in the first half, fueling double-digit growth in smaller customer segments and functional surfactants. The polymers business is leveraging spray foam, which grew volumes 3x year over year from a low base, signaling a new avenue for share capture in building insulation.
4. Capital Allocation and Balance Sheet Focus
Despite a temporary working capital build, Stepan maintained its commitment to cash generation and balance sheet deleveraging. The company paid $9 million in dividends and continues to prioritize prudent capex, with a focus on projects that enhance network efficiency and support strategic growth. Asset monetization, such as the pending Joliet land sale, is also in progress.
Key Considerations
This quarter’s results reflect the intersection of steady execution and transitory market dynamics. While operational execution was strong, some earnings strength was driven by factors unlikely to persist, such as pre-buying and raw material volatility.
Key Considerations:
- Customer Inventory Behavior: Pre-buying added $5–$10 million to EBITDA, signaling a likely normalization in second-half demand.
- Raw Material Volatility: Price swings in key inputs (e.g., coconut oil, petrochemicals) create margin unpredictability and complicate forecasting.
- Project Catalyst Run-Rate: Most cost savings are now realized or announced, with incremental gains dependent on further asset optimization and network rationalization.
- Pasadena Ramp-Up: The Texas site is nearing full utilization, which should support future specialty product growth and supply chain savings.
- Segment Mix Shift: Functional surfactants and spray foam polymers are growing faster than legacy markets, gradually tilting the portfolio toward higher-value applications.
Risks
Raw material cost swings and geopolitical disruptions remain the most acute risks, potentially impacting both volumes (via customer inventory strategies) and margins (through cost pass-through lags). Execution risk around Project Catalyst persists, especially as remaining savings require more complex footprint and workforce actions. End-market demand in Europe and Asia is still uneven, and a return to “just-in-time” inventory management could create temporary volume headwinds. Management is not providing detailed guidance, adding to forecasting uncertainty.
Forward Outlook
For Q3, Stepan signaled:
- EBITDA is expected to be lower sequentially as pre-buying and margin tailwinds normalize.
- Maintenance turnarounds in polymers will reduce second-half earnings by $4–$5 million.
For full-year 2026, management reiterated:
- Commitment to positive free cash flow, continued deleveraging, and full-year adjusted EBITDA growth.
- Delivery of $60+ million in Project Catalyst savings, tracking toward a $100 million run-rate by next year.
Management highlighted:
- Focus on growth in crop productivity, oilfield, Tier 2/3 surfactants, and North America polymers.
- Continued asset optimization and cash discipline as key levers to drive long-term value.
Takeaways
Stepan’s Q2 2026 results mark a turning point in profitability, but the sustainability of gains will depend on margin discipline and further asset optimization.
- Cost-Out and Margin Leverage: Project Catalyst is delivering tangible savings, but incremental upside will require deeper network and workforce rationalization.
- Volume Normalization Ahead: Pre-buying and raw material-driven demand pulled forward earnings, setting up a more muted second half.
- Strategic Mix Shift: Growth in functional surfactants and spray foam polymers is gradually repositioning the portfolio toward higher-value, less commoditized applications.
Conclusion
Stepan’s Q2 performance showcased the combined power of operational discipline and strategic cost-out, but the path forward will demand careful navigation of raw material volatility and customer inventory swings. Investors should track margin sustainability, Project Catalyst execution, and the evolving mix toward higher-value segments.
Industry Read-Through
Stepan’s results reinforce a sector-wide theme of margin recovery and operational streamlining in specialty chemicals, as companies deploy cost-out programs to offset persistent input volatility. Customer pre-buying and “just-in-case” inventory strategies remain prevalent, but are likely to fade as supply chains stabilize. Peers with exposure to functional surfactants, polyols, and insulation markets may see similar volume and margin dynamics, though the sustainability of these gains will hinge on differentiated product mix and the ability to execute on footprint rationalization. Raw material pass-through discipline and asset optimization will remain central themes across the chemicals industry through 2026.